Ernest Palomeras

Ernest Palomeras

Auto-generated profile, based on publicly available information

Ernest Palomeras

Neurology Department, Hospital de Mataró, Mataró, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Current Cardiology Reviews
Verified
Journal Article
Open access
ESErnest Palomeras Soler
Ernest Palomeras Soler
VRVirgina Casado Ruiz
Virgina Casado Ruiz
Cerebral ischemia and ischemic heart diseases, common entities nowadays, are the main manifestation of circulatory diseases. Cardiovascular diseases, followed by stroke, represent the leading cause of mortality worldwide. Both entities share risk factors, pathophisiology and etiologic aspects by means of a main common mechanism, atherosclerosis. However, each entity has its own particularities. Ischemic stroke shows a variety of pathogenic mechanisms not present in ischemic heart disease. An ischemic stroke increases the risk of suffering a coronary heart disease, and viceversa. The aim of this chapter is to review data on epidemiology, pathophisiology and risk factors for both entities, considering the differences and similarities that could be found in between them. We discuss traditional risk factors, obtained from epidemiological data, and also some novel ones, such as hyperhomocisteinemia or sleep apnea. We separate risk factors, as clasically, in two groups: nonmodifiables, which includes age, sex, or ethnicity, and modifiables, including hypertension, dyslipidemia or diabetis, in order to discuss the role of each factor in both ischemic events, ischemic stroke and coronary heart disease.

23 March 2018 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
LRLaia Rofes
Laia Rofes
DMD. Muriana
D. Muriana
EPE. Palomeras
E. Palomeras
NVN. Vilardell
N. Vilardell
EPElisabet Palomera
Elisabet Palomera
Pere ClavéPere Clavé
Pere Clavé

11 July 2016 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CCChristopher Cabib
Christopher Cabib
OOOmar Ortega
Omar Ortega
HKHatice Kumru
Hatice Kumru
EPErnest Palomeras
Ernest Palomeras
NVNatalia Vilardell
Natalia Vilardell
Pere ClavéPere Clavé
Pere Clavé

8 April 2008 in Neurology
Verified
Journal Article
Closed access
PDF file
NON. Pérez de la Ossa
N. Pérez de la Ossa
JSJ. Sánchez-Ojanguren
J. Sánchez-Ojanguren
EPE. Palomeras
E. Palomeras
MMM. Millán
M. Millán
JAJ. F. Arenillas
J. F. Arenillas
ADA. Dávalos
A. Dávalos
Introduction: In our metropolitan area, the Stroke Code (SC) system allows immediate transfer of patients with acute stroke to a stroke center. It may be activated by community hospitals (A), emergency medical services (EMS, B), or the emergency department of the stroke center (C). Our aim was to analyze whether the SC activation source influences the access to thrombolytic therapy and outcome of patients with ischemic stroke. Methods: We prospectively registered patients with ischemic stroke admitted to the acute stroke unit who arrived through the SC system. The primary outcome variable was good outcome at discharge (Rankin Scale ≤ 2). Secondary outcome was neurologic improvement ≥4 in National Institutes of Health Stroke Scale (NIHSS) score or NIHSS score 0 to 1 at 24 hours. Results: A total of 262 consecutive patients with hyperacute ischemic stroke were studied; the SC source was A in 112, B in 57, and C in 92. Median time from onset to admission was longer in Group A and stroke severity higher in Groups B and C. Percentage of tPA administration was higher in patients from Groups B and C (27%, 54%, and 46% of patients; p = 0.001). With respect to Group A, Group B was associated with good outcome with an odds of 2.9 (1.2–6.6; p = 0.01), and Group C with an odds of 2.4 (1.1–4.9; p = 0.01) after adjustment for age and stroke severity at baseline. Patients coming via levels B and C were more likely to improve at 24 hours. Conclusions: Patients arriving directly to the stroke center via emergency medical services or on their own receive neurologic attention sooner, are more frequently treated with tPA, and have better clinical outcome than those patients who are first taken to a community hospital.

4 January 2019 in Circulation Research
Verified
Journal Article
Closed access
MMMarina Mola-Caminal
Marina Mola-Caminal
CCCaty Carrera
Caty Carrera
CSCarolina Soriano-Tárraga
Carolina Soriano-Tárraga
EGEva Giralt-Steinhauer
Eva Giralt-Steinhauer
RDRosa M. Díaz-Navarro
Rosa M. Díaz-Navarro
JJJordi Jiménez-Conde
Jordi Jiménez-Conde
Rationale:: Ischemic stroke is among the leading causes of adult disability. Part of the variability in functional outcome after stroke has been attributed to genetic factors but no locus has been consistently associated with stroke outcome. Objective:: Our aim was to identify genetic loci influencing the recovery process using accurate phenotyping to produce the largest GWAS (genome-wide association study) in ischemic stroke recovery to date. Methods and Results:: A 12-cohort, 2-phase (discovery-replication and joint) meta-analysis of GWAS included anterior-territory and previously independent ischemic stroke cases. Functional outcome was recorded using 3-month modified Rankin Scale. Analyses were adjusted for confounders such as discharge National Institutes of Health Stroke Scale. A gene-based burden test was performed. The discovery phase (n=1225) was followed by open (n=2482) and stringent joint-analyses (n=1791). Those cohorts with modified Rankin Scale recorded at time points other than 3-month or incomplete data on previous functional status were excluded in the stringent analyses. Novel variants in PATJ (Pals1-associated tight junction) gene were associated with worse functional outcome at 3-month after stroke. The top variant was rs76221407 (G allele, β=0.40, P =1.70×10 −9 ). Conclusions:: Our results identify a set of common variants in PATJ gene associated with 3-month functional outcome at genome-wide significance level. Future studies should examine the role of PATJ in stroke recovery and consider stringent phenotyping to enrich the information captured to unveil additional stroke outcome loci.

27 June 2021 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
SMSergio Marin
Sergio Marin
MSMateu Serra-Prat
Mateu Serra-Prat
OOOmar Ortega
Omar Ortega
MFMonica Audouard Fericgla
Monica Audouard Fericgla
JVJordi Valls
Jordi Valls
Pere ClavéPere Clavé
Pere Clavé
Background and purpose: The healthcare economic costs of post‐stroke oropharyngeal dysphagia (OD) are not fully understood. The purpose of this study was to assess the acute, subacute and long‐term costs related to post‐stroke OD and its main complications (malnutrition and respiratory infections).Methods: A cost of illness study of patients admitted to Mataró Hospital (Catalonia, Spain) from May 2010 to September 2014 with a stroke diagnosis was performed. OD, malnutrition and respiratory infections were assessed during hospitalization and follow‐up (3 and 12 months). Hospitalization and long‐term costs were measured from hospital and healthcare system perspectives. Multivariate linear regression analysis was performed to assess the independent effect of OD, malnutrition and respiratory infections on healthcare costs during hospitalization, and at 3 and 12 months’ follow‐up.Results: In all, 395 patients were included of whom 178 had OD at admission. Patients with OD incurred major total in‐hospital costs (€5357.67 ± €3391.62 vs. €3976.30 ± €1992.58, p < 0.0001), 3‐month costs (€8242.0 ± €5376.0 vs. €5320.0 ± €4053.0, p < 0.0001) and 12‐month costs (€11,617.58 ± €12,033.58 vs. €7242.78 ± €7402.55, p < 0.0001). OD was independently associated with a cost increase of €789.68 (p = 0.011) during hospitalization and of €873.5 (p = 0.084) at 3 months but not at 12 months. However, patients with OD who were at risk of malnutrition or malnourished and suffered respiratory infections incurred major mean costs compared with those patients without OD (€19,817.58 ± €13,724.83 vs. €7242.8 ± €7402.6, p < 0.0004) at 12 months’ follow‐up.Conclusion: Oropharyngeal dysphagia causes significant high economic costs during hospitalization that strongly and significantly increase with the development of malnutrition and respiratory infections at long‐term follow‐up.